Malik Juweid

Citée par

	Toutes	Depuis 2019
Citations	16137	3678
indice h	47	17
indice i10	95	33

1100

550

275

825

19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202448 58 160 123 240 236 226 252 231 228 272 358 551 659 665 779 849 907 981 1029 942 879 769 726 715 752 768 649 597 195

Accès public

Tout afficher

10 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Felix MottaghyDepartment of Nuclear Medicine, University Hospital RWTH Aachen UniversityAdresse e-mail validée de ukaachen.de
Randy D GascoyneProfessor of Pathology, University of British ColumbiaAdresse e-mail validée de bccancer.bc.ca
Sigrid StroobantsAdresse e-mail validée de uantwerpen.be
Abass AlaviUPENNAdresse e-mail validée de uphs.upenn.edu
Lena SpechtProfessor i onkologi, Københavns UniversitetAdresse e-mail validée de regionh.dk
Richard HoppeProfessor of Radiation Oncology, Stanford UniversityAdresse e-mail validée de stanford.edu
Richard I. FisherPresident & CEO, Fox Chase Cancer Center, Temple UniversityAdresse e-mail validée de fccc.edu
Martin DreylingProfessor of Medicine, University of MunichAdresse e-mail validée de med.uni-muenchen.de
Cun-Hui ZhangDistinguished Professor, Dept of Statistics & Biostatistics, Rutgers UniversityAdresse e-mail validée de stat.rutgers.edu
Markus SchwaigerUCLA,University of Michigan,Technische Universität MünchenAdresse e-mail validée de tum.de
Ali GuermaziProfessor of Radiology, Boston University School of MedicineAdresse e-mail validée de bu.edu
Josée ZijlstraAssociate Professor of Hematology, VU University Medical Center, AmsterdamAdresse e-mail validée de vumc.nl
Gerhard GlattingProfessor of Medical Radiation Physics, Ulm UniversityAdresse e-mail validée de uni-ulm.de
Professor Rod HicksDepartment of Medicine, St Vincent's Hospital, the University of Melbourne and Department ofAdresse e-mail validée de mtic.net.au
Ronald D. Neumann, M.D.Chief Nuclear Medicine, Clinical Center, NIHAdresse e-mail validée de nih.gov
John N WeinsteinMD Anderson Cancer CenterAdresse e-mail validée de mdanderson.org
Emmanuel IttiProfesseur de Médecine Nucléaire, Hôpitaux universitaires Henri MondorAdresse e-mail validée de aphp.fr
Johan W.S. VlaeyenProfessor of Behavioral Medicine, University of Leuven, Belgium and Maastricht UniversityAdresse e-mail validée de kuleuven.be
David M. GoldenbergFounder and Emeritus Chairman of the Board, Immunomedics, Inc.

Suivre

Malik Juweid

Professor of Radiology, University of Jordan

Adresse e-mail validée de ju.edu.jo

nuclear medicine molecular imaging positron emission tomography radioimmunotherapy radionuclide therapy


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Revised response criteria for malignant lymphoma BD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ... Journal of clinical oncology 25 (5), 579-586, 2007	5273	2007
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ... Journal of clinical oncology 25 (5), 571-578, 2007	1671	2007
Positron-emission tomography and assessment of cancer therapy ME Juweid, BD Cheson New England Journal of Medicine 354 (5), 496-507, 2006	920	2006
Epidemiology and outcome of glioblastoma AF Tamimi, M Juweid Exon Publications, 143-153, 2017	610	2017
Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats MJ Abrams, M Juweid, DA Schwartz, MM Hauser, FE Gaul, AJ Fuccello, ... Journal of Nuclear Medicine 31 (12), 2022-2028, 1990	550	1990
Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier M Juweid, R Neumann, C Paik, MJ Perez-Bacete, J Sato, W van Osdol, ... Cancer research 52 (19), 5144-5153, 1992	510	1992
Response assessment of aggressive non-Hodgkin’s lymphoma by Integrated International Workshop criteria and fluorine-18–fluorodeoxyglucose positron emission tomography ME Juweid, GA Wiseman, JM Vose, JM Ritchie, Y Menda, JE Wooldridge, ... Journal of Clinical Oncology 23 (21), 4652-4661, 2005	490	2005
The role of FDG-PET scans in patients with lymphoma P Seam, ME Juweid, BD Cheson Blood, The Journal of the American Society of Hematology 110 (10), 3507-3516, 2007	391	2007
AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development SN Khleif, JH Doroshow, WN Hait Clinical Cancer Research 16 (13), 3299-3318, 2010	229	2010
Molecular imaging of proliferation in malignant lymphoma AK Buck, M Bommer, S Stilgenbauer, M Juweid, G Glatting, ... Cancer research 66 (22), 11055-11061, 2006	213	2006
Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives TM Behr, RM Sharkey, ME Juweid, RD Blumenthal, RM Dunn, GL Griffiths, ... Cancer research 55 (17), 3825-3834, 1995	211	1995
Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG TM Behr, RM Sharkey, ME Juweid, RM Dunn, RC Vagg, Z Ying, ... Journal of Nuclear Medicine 38 (6), 858-870, 1997	175	1997
Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody M Juweid, RM Sharkey, A Markowitz, T Behr, LC Swayne, R Dunn, ... Cancer Research 55 (23_Supplement), 5899s-5907s, 1995	170	1995
Role of positron emission tomography in lymphoma ME Juweid, BD Cheson Journal of Clinical Oncology 23 (21), 4577-4580, 2005	165	2005
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study SJ Horning, ME Juweid, H Schöder, G Wiseman, A McMillan, LJ Swinnen, ... Blood, The Journal of the American Society of Hematology 115 (4), 775-777, 2010	156	2010
International Harmonization Project on Lymphoma BD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ... Revised response criteria for malignant lymphoma. J Clin Oncol 25 (5), 579-586, 2007	155	2007
Pharmacokinetics, Dosimetry, and Initial Therapeutic Results with ¹³¹I- and ¹¹¹In-⁹⁰Y-Labeled Humanized LL2 Anti-CD22 Monoclonal Antibody in Patients with … ME Juweid, E Stadtmauer, G Hajjar, RM Sharkey, S Suleiman, S Luger, ... Clinical cancer research 5 (10), 3292s-3303s, 1999	155	1999
Radioimmunotherapy of B-cell non-Hodgkin’s lymphoma: from clinical trials to clinical practice ME Juweid Journal of Nuclear Medicine 43 (11), 1507-1529, 2002	154	2002
Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies RM Sharkey, M Juweid, J Shevitz, T Behr, R Dunn, LC Swayne, GY Wong, ... Cancer Research 55 (23_Supplement), 5935s-5945s, 1995	121	1995
Radioimmunotherapy of non-Hodgkin’s lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response? RM Sharkey, A Brenner, J Burton, G Hajjar, SP Toder, A Alavi, A Matthies, ... Journal of Nuclear Medicine 44 (12), 2000-2018, 2003	120	2003

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs